cj red bio anticancer drug
Scope
Date
~
-
Food & Beverage
CJ Foodville goes global from in-flight meals to Starbucks bread
CJ Foodville Co., a South Korean food company, is deepening its presence in Southeast Asia with premium bakery products, catering to airplane passen...
Jun 04, 2025 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics to spin off biosimilar unit Samsung Bioepis
Samsung Biologics Co., the world’s largest contract drugmaker, will undergo a strategic split to separate its contract development and manufac...
May 22, 2025 (Gmt+09:00)
-
Korean food
CJ CheilJedang to open $72 million dumpling plant in Japan
South Korea’s largest food company, CJ CheilJedang Corp., is shifting into high gear in its global expansion with a 100 billion won ($72 milli...
May 08, 2025 (Gmt+09:00)
-
Mergers & Acquisitions
CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
CJ CheilJedang Corp., South Korea’s largest food and beverage company, said on Wednesday it has scrapped a planned sale of its green bio busin...
Apr 30, 2025 (Gmt+09:00)
-
Mergers & Acquisitions
CJ CheilJedang scraps sale of Brazilian unit CJ Selecta to Bunge
CJ CheilJedang Corp., South Korea’s largest food company, has cancelled the sale of a 66% stake in Brazilian soybean crusher CJ Selecta S.A. a...
Apr 29, 2025 (Gmt+09:00)
-
Bio & Pharma
Celltrion unveils cancer medicine to expand new drug pipelines
South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...
Apr 28, 2025 (Gmt+09:00)
-
Bio & Pharma
Celltrion expands footprint in Latin America with flagship oncology drugs
South Korea’s biopharmaceutical giant Celltrion Inc. has solidified its presence in South America after winning supply contracts for its flags...
Apr 17, 2025 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins Australian approval for eye, bone disease biosimilars
Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...
Apr 10, 2025 (Gmt+09:00)
-
Bio & Pharma
ABL Bio lands $2.8 billion license-out deal with GSK
ABL Bio Inc., a South Korean biotech company, will license out its proprietary blood-brain barrier shuttle platform, called the Grabody-B, to UK-bas...
Apr 07, 2025 (Gmt+09:00)
-
Bio & Pharma
Celltrion to sell autoimmune drug Stelara biosimilar at Costco in US
South Korea’s leading biosimilar drug developer Celltrion Inc. said on Monday it is set to sell Steqeyma, a biosimilar to autoimmune disease t...
Mar 25, 2025 (Gmt+09:00)
-
Bio & Pharma
SillaJen: First to use lab-grown human tissue to find best cancer drug dose
South Korean biotechnology firm SillaJen Inc. is pioneering a new approach to determine the best dose for a cancer drug combination in clinical tria...
Mar 18, 2025 (Gmt+09:00)
-
Private equity
Red flags raised even before Homeplus crisis: Sales fall, credit ratings cut
Even before South Korea’s second-largest hypermarket chain Homeplus Co. was put under court receivership due to its worsening financial woes, ...
Mar 18, 2025 (Gmt+09:00)
-
Beauty & Cosmetics
K-beauty shake-up: APR, Shinsegae rise as Aekyung declines
South Korea’s beauty industry is undergoing a major reshuffle, with new players rising to prominence while established giants face growing com...
Mar 12, 2025 (Gmt+09:00)
-
Mergers & Acquisitions
MBK Partners poised to acquire CJ Cheiljedang’s $3.5 billion bio business
North Asia-focused private equity firm MBK Partners is on the verge of clinching a major acquisition deal by offering a higher bid than other conten...
Mar 06, 2025 (Gmt+09:00)
-
Bio & Pharma
Chong Kun Dang to build new plant for foray into biologics market
Chong Kun Dang Pharmaceutical Corp. is discussing building a research center and a plant in Siheung, about 30 kilometers southwest of Seoul, with th...
Feb 27, 2025 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins EU approval for autoimmune disease treatment Avtozma
Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...
Feb 25, 2025 (Gmt+09:00)
-
Real estate
Beauty giant CJ Olive Young to buy Seoul office building for $472 mn
CJ Olive Young Corp., South Korea’s top beauty store chain, has been given priority rights to buy an office building in Seoul for about 680 bi...
Feb 19, 2025 (Gmt+09:00)
-
Mergers & Acquisitions
MBK Partners, 2 Chinese firms vie for CJ Cheiljedang’s $4 bn bio business
North Asia-focused private equity firm MBK Partners and two leading Chinese biotechnology firms are vying for management control of CJ Cheiljedang C...
Feb 13, 2025 (Gmt+09:00)
-
Beauty & Cosmetics
Korea’s beauty retailer CJ Olive Young to open first US offline outlet
CJ Olive Young Corp., South Korea’s top beauty store chain, said on Tuesday it has set up a US business entity in Los Angeles to enhance its p...
Feb 04, 2025 (Gmt+09:00)
-
Bio & Pharma
Lotte Biologics eyes first ADC CDMO order in 2025
SAN FRANCISCO -- Lotte Biologics Co., the drug consignment development and production unit of South Korean conglomerate Lotte Group, will seek to wi...
Jan 17, 2025 (Gmt+09:00)
-
IPOs
Celltrion seeks large-scale M&A in Q4, eyes 2027 Nasdaq debut
SAN FRANCISCO – South Korea’s leading biosimilar drug developer Celltrion Inc. seeks to acquire a domestic health food maker as early as...
Jan 16, 2025 (Gmt+09:00)
-
Bio & Pharma
SK Biopharmaceuticals, Eurofarma to set up AI epilepsy platform JV in US
South Korea’s SK Biopharmaceuticals Co. has signed a deal with Brazil’s Eurofarma Laboratórios S.A. to establish a joint venture ...
Jan 15, 2025 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics signs initial deal with LigaChem Bio on ADC production
Samsung Biologics Co., the world’s largest contract drugmaker, said on Thursday it has signed an initial agreement with LigaChem Biosciences I...
Jan 09, 2025 (Gmt+09:00)
-
Bio & Pharma
Yuhan’s lung cancer drug gets OK in Europe
Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...
Dec 31, 2024 (Gmt+09:00)
-
Bio & Pharma
Boryung, Lotus Pharma signs CDMO deal on anticancer injection
South Korea's Boryung Corp. said on Thursday it signed a contract with Lotus Pharmaceutical, a Taiwanese oncology firm, for contract development and...
Dec 12, 2024 (Gmt+09:00)
-
Chemical Industry
HD Hyundai Oilbank supplies bio VLSFO to Yangming
HD Hyundai Oilbank Co., a South Korean crude oil refiner backed by Saudi Aramco, said on Thursday it started to supply Taiwan-based Yang Ming Marine...
Dec 12, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm submits NDA of epilepsy drug to China
South Korea's SK Biopharmaceuticals Co. said on Tuesday it submitted the new drug application (NDA) for its flagship epilepsy drug Cenobamate to Chi...
Dec 05, 2024 (Gmt+09:00)
-
Cloud computing
CJ OliveNetworks to expand cloud management biz
South Korea's CJ OliveNetworks said on Wednesday it will expand its managed service provider (MSP) in the cloud industry, utilizing Naver Cloud and ...
Dec 04, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Blackstone, Carlyle, MBK vying for CJ CheilJedang’s bio business
Blackstone, Carlyle Group and MBK Partners have joined the race to purchase the bio business of CJ CheilJedang Corp., the world’s largest prod...
Dec 02, 2024 (Gmt+09:00)
-
Business & Politics
Latvian President Rinkēvičs seeks closer ties with S.Korea in bio, defense
Latvian President Edgars Rinkēvičs, who is on a four-day working trip to South Korea, said on Friday he hopes for deeper cooperation between the two...
Nov 29, 2024 (Gmt+09:00)
Latest News
- 1 Coupang bids for Korean luxury market dominance with Farfetch
- 2 Hyundai Rotem set to finalize $6 bn K2 tank order from Poland
- 3 Lee Jae-myung to meet with top business leaders this week ahead of G7 summit
- 4 Korea to allow non-profits to buy bad consumer loans
- 5 LG to drive future growth in emerging markets with battery prowess